erlotinib hydrochloride has been researched along with Mole, Skin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eichenfield, DZ; Orme, CM; Seidman, JS | 1 |
1 other study(ies) available for erlotinib hydrochloride and Mole, Skin
| Article | Year |
|---|---|
Nevoid melanoma and eruptive nevi from erlotinib.
Topics: Aged; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Melanoma; Nevus; Protein Kinase Inhibitors; Skin Neoplasms | 2020 |